Event Date: December 13-15, 2017

Two teams from Universitas Indonesia (UI) & University of Gadjah Mada (UGM) are investigating the cost-effectiveness of two high-priced drugs – cetuximab and bevacizumab. Both teams require NMA to compare cetuximab/bevacizumab with a common comparator. NMA is crucial for these studies to obtain standardized results using the most scientific method.
The participants attending the workshop have a diverse range of backgrounds, including medical practitioners, economists, pharmacists, and academics. This workshop is funded by international Decision Support Initiative (iDSI).